DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Letairis (Ambrisentan) - Current Clinical Trials


Letairis Related Clinical Trials

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis [Recruiting]

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis [Recruiting]

Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension [Recruiting]

Efficacy and Safety of Ambrisentan in Children 8-18yrs [Recruiting]

(ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF [Recruiting]

An Observational Study For Ambrisentan [Recruiting]

Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension [Recruiting]

Influence of CYP3A4-induction by St. John's Wort (SJW) on the Steady State Pharmacokinetics of Ambrisentan [Recruiting]

The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study [Not yet recruiting]

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial [Recruiting]

Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension [Recruiting]

A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Recruiting]

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis [Recruiting]

Ambrisentan for Treatment of Portopulmonary Hypertension [Recruiting]

Ambrisentan in Single Ventricle [Not yet recruiting]

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension [Recruiting]

Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension. [Recruiting]

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan [Recruiting]

A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). [Recruiting]

Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan [Recruiting]

An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension [Recruiting]

The Effects of Ambrisentan on Exercise Capacity in Fontan Patients [Recruiting]

Pharmacogenomics in Pulmonary Arterial Hypertension [Recruiting]

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 [Recruiting]

Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With TyvasoŽ Compared to Other FDA Approved Pulmonary Arterial Hypertension (PAH) Therapies [Recruiting]

Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma [Not yet recruiting]

Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) [Not yet recruiting]


Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) [Recruiting]

A Study to Evaluate GSK1325760A - a Long-Term Extension Study [Recruiting]

Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension [Recruiting]

A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015